Published in AJR Am J Roentgenol on June 01, 2010
Positive predictive value of BI-RADS MR imaging. Radiology (2012) 1.46
Navigating Latinas with breast screen abnormalities to diagnosis: the Six Cities Study. Cancer (2012) 1.12
Intra-individual randomised comparison of gadobutrol 1.0 M versus gadobenate dimeglumine 0.5 M in patients scheduled for preoperative breast MRI. Eur Radiol (2012) 1.10
High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer? Eur Radiol (2011) 0.95
Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T. Eur Radiol (2013) 0.90
Factors Associated with Re-excision after Breast-Conserving Surgery for Early-Stage Breast Cancer. J Breast Cancer (2012) 0.88
Pearls and pitfalls in breast MRI. Br J Radiol (2011) 0.87
Predictive performance of BI-RADS magnetic resonance imaging descriptors in the context of suspicious (category 4) findings. Radiol Bras (2016) 0.86
The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast. J Magn Reson Imaging (2011) 0.84
A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography. Eur Radiol (2013) 0.83
Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications. PLoS One (2014) 0.81
3D parallel-detection microwave tomography for clinical breast imaging. Rev Sci Instrum (2014) 0.81
Identification of Breast Cancer Using Integrated Information from MRI and Mammography. PLoS One (2015) 0.79
Computer-aided evaluation as an adjunct to revised BI-RADS Atlas: improvement in positive predictive value at screening breast MRI. Eur Radiol (2014) 0.79
A simple scoring system for breast MRI interpretation: does it compensate for reader experience? Eur Radiol (2015) 0.79
Magnetic Resonance Imaging Features of Adenosis in the Breast. J Breast Cancer (2015) 0.78
Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T. Eur J Nucl Med Mol Imaging (2015) 0.78
Current and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management. P R Health Sci J (2010) 0.77
Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up. J Thorac Dis (2013) 0.77
Value of the BI-RADS classification in MR-Mammography for diagnosis of benign and malignant breast tumors. Eur Radiol (2011) 0.77
A simple classification system (the Tree flowchart) for breast MRI can reduce the number of unnecessary biopsies in MRI-only lesions. Eur Radiol (2017) 0.77
MRI in the differential diagnosis of primary architectural distortion detected by mammography. Diagn Interv Radiol (2016) 0.76
Differentiation of Malignant and Benign Incidental Breast Lesions Detected by Chest Multidetector-Row Computed Tomography: Added Value of Quantitative Enhancement Analysis. PLoS One (2016) 0.75
Kinetic Curve Type Assessment for Classification of Breast Lesions Using Dynamic Contrast-Enhanced MR Imaging. PLoS One (2016) 0.75
Pathologic findings in MRI-guided needle core biopsies of the breast in patients with newly diagnosed breast cancer. Int J Breast Cancer (2010) 0.75
Novel nano-sized MR contrast agent mediates strong tumor contrast enhancement in an oncogene-driven breast cancer model. PLoS One (2014) 0.75
The clinical significance of accompanying NME on preoperative MR imaging in breast cancer patients. PLoS One (2017) 0.75
Post-clip placement MRI following second-look US-guided core biopsy for suspicious lesions identified on breast MRI. Eur Radiol (2017) 0.75
Kinetic analysis of lesions without mass effect on breast MRI using manual and computer-assisted methods. Eur Radiol (2010) 0.75
Diffusion-weighted imaging of suspicious (BI-RADS 4) breast lesions: stratification based on histopathology. Radiol Bras (2017) 0.75
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol (2008) 3.64
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial. J Natl Cancer Inst (2013) 3.46
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62
Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) (2009) 2.14
Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol (2013) 2.00
A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma. J Urol (2011) 1.91
Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol (2010) 1.84
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. J Clin Oncol (2010) 1.71
Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest Radiol (2002) 1.61
In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography. Arthritis Res Ther (2010) 1.60
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci U S A (2010) 1.60
Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol (2007) 1.58
Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum (2008) 1.53
Ultrasound-guided biopsy of homogenous solid renal masses. Eur Urol (2007) 1.44
Non-random integration of the HPV genome in cervical cancer. PLoS One (2012) 1.43
Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice. Arthritis Res Ther (2011) 1.42
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Assessment of skeletal age at the wrist in children with a new ultrasound device. Pediatr Radiol (2005) 1.35
The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther (2005) 1.34
Diffusion tensor imaging: the normal evolution of ADC, RA, FA, and eigenvalues studied in multiple anatomical regions of the brain. Neuroradiology (2009) 1.33
Expression of splicing factors in human ovarian cancer. Oncol Rep (2004) 1.31
Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol (2005) 1.27
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One (2011) 1.20
Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol (2005) 1.15
Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome. Arch Orthop Trauma Surg (2008) 1.15
Wallerian degeneration of pyramidal tract after paramedian pons infarct. Cerebrovasc Dis (2010) 1.15
Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol (2004) 1.12
Influence of breast lesion size and histologic findings on tumor detection rate of a computer-aided detection system. Radiology (2003) 1.11
Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T--systematic review and meta-analysis. Radiology (2013) 1.09
Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. J Clin Virol (2009) 1.09
Cortical blindness after contrast-enhanced CT: complication in a patient with diabetes insipidus. AJNR Am J Neuroradiol (2003) 1.07
Case report: primary carcinoid tumor of the testicle without metastases in combination with testicular atrophy and testosterone deficiency. Int Urol Nephrol (2006) 1.06
Early diagnosis of cerebral involvement in Sturge-Weber syndrome using high-resolution BOLD MR venography. Pediatr Radiol (2004) 1.05
Influence of image-capturing parameters on digital X-ray radiogrammetry. J Clin Densitom (2005) 1.04
Heating potential of iron oxides for therapeutic purposes in interventional radiology. Acad Radiol (2002) 1.03
Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years. Pharmacogenetics (2002) 1.03
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. Cancer Gene Ther (2002) 1.03
Loss of gene function as a consequence of human papillomavirus DNA integration. Int J Cancer (2012) 1.03
Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol (2005) 1.02
Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol (2002) 1.02
In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum (2004) 1.02
Time course of diffusion imaging in acute brainstem infarcts. J Magn Reson Imaging (2007) 1.01
Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochem Cell Biol (2012) 1.00
Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes. Acta Radiol (2010) 1.00
Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis. Pain (2009) 0.99
Diffusion tensor magnetic resonance imaging of the breast: a pilot study. Eur Radiol (2010) 0.99
Ultrasound-guided, percutaneous cryotherapy of small (< or = 15 mm) breast cancers. Invest Radiol (2005) 0.99
Time-resolved functional 1H MR spectroscopic detection of glutamate concentration changes in the brain during acute heat pain stimulation. Neuroimage (2009) 0.99
Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis. Arthritis Res Ther (2010) 0.99
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99
Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model. Biol Chem (2008) 0.98
The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases. Korean J Radiol (2010) 0.98
Resolving arterial phase and temporal enhancement characteristics in DCE MRM at high spatial resolution with TWIST acquisition. J Magn Reson Imaging (2011) 0.97
Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine (Lond) (2012) 0.97
Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z Med Phys (2006) 0.96
The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses. Ann Rheum Dis (2011) 0.95
FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers. Int Urol Nephrol (2014) 0.95
Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol (2009) 0.93
Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications. Phys Med Biol (2009) 0.93
MR Imaging in Wegener granulomatosis of the spinal cord. AJNR Am J Neuroradiol (2003) 0.93
Diagnosis of arthritis using near-infrared fluorochrome Cy5.5. Invest Radiol (2004) 0.93
Radio-frequency tumor ablation: internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model. Radiology (2002) 0.92
The coxsackie adenovirus receptor inhibits cancer cell migration. Exp Cell Res (2004) 0.92
Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma. J Urol (2011) 0.92
Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy. J Cancer Res Clin Oncol (2010) 0.92
Computerized quantification of joint space narrowing and periarticular demineralization in patients with rheumatoid arthritis based on digital x-ray radiogrammetry. Invest Radiol (2006) 0.92
In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice. Radiology (2008) 0.91
Normative data for digital X-ray radiogrammetry from a female and male German cohort. J Clin Densitom (2006) 0.91
Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis. Arthritis Res Ther (2010) 0.91
Computerized digital imaging techniques provided by digital X-ray radiogrammetry as new diagnostic tool in rheumatoid arthritis. J Digit Imaging (2006) 0.90
Hepatic Fibrosis in a Long-term Murine Model of Sepsis. Shock (2012) 0.90
Differential diagnosis of breast lesions 5 mm or less: is there a role for magnetic resonance imaging? J Comput Assist Tomogr (2010) 0.90
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res (2013) 0.89
Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy. Clin Res Cardiol (2012) 0.89
Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol (2008) 0.89
Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res (2004) 0.89
An in vitro characterization study of new near infrared dyes for molecular imaging. Eur J Med Chem (2009) 0.88
Voiding urosonography with ultrasonography contrast medium in children. Pediatr Nephrol (2002) 0.88
Computer-aided joint space analysis of the metacarpal-phalangeal and proximal-interphalangeal finger joint: normative age-related and gender-specific data. Skeletal Radiol (2007) 0.88
Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? evaluation of an extended protocol in an initial prospective study. AJR Am J Roentgenol (2011) 0.88
Fluorescent bacterial magnetic nanoparticles as bimodal contrast agents. Invest Radiol (2007) 0.88